INTRODUCTION
============

In addition to the classical direct spinocerebellar pathways, indirect pathways exist that convey information from the spinal cord to the cerebellum ([@B6],[@B7]; [@B3]). These pathways consist of SRT neurons that form synaptic connections with pre-cerebellar neurons located in the medullary reticular formation. The principal pre-cerebellar nucleus involved in this spino-bulbar-cerebellar pathway is the LRt which contains neurons that are known to have highly ordered projections to different regions of the cerebellar cortex and deep cerebellar nuclei. ([@B8]; [@B26]; [@B29]; [@B11]; [@B20]; [@B30]; [@B45]). Lesions of the LRt cause disruption of posture and balance ([@B10]; [@B39]) and the LRt degenerates in spinocerebellar ataxia type 3 (Marcado--Joseph Disease) which is characterized by severe limb and gait ataxia ([@B38]) thus confirming its importance in motor integration.

Electrophysiological studies have shown that at least three distinct spinal pathways project to the LRt. These include two pathways that originate from cervical segments, the iFT and the C3--C4 propriospinal system (see [@B1]). A third pathway, the bVFRT projects from all spinal levels. In addition to these spinal pathways, LRt cells can also be activated from a number of other brain regions including, the trigeminal nerve, the rubrospinal tract, superior colliculus, and motor cortex (see [@B1]). This pattern of connectivity suggests that the LRt has an important role in coordinating motor activity by integrating information from the spinal cord and various regions of the brain ([@B10]). [@B1] have suggested that the cerebellum compares integrated information from the LRt with segregated information conveyed by the classical spinocerebellar pathways in order to adjust errors in motor programs.

In rats and in cats, unilateral injections of retrograde tracer within the LRt label cells at all segmental levels. Most cells are labeled contralateral to LRt injection sites, and in the lumbar cord, are concentrated within laminae VII, VIII, and X ([@B9]; [@B19]; [@B30]; [@B42]). Lesion and tracing studies also reveal that spinal neurons form numerous terminations within the LRt ([@B4]; [@B34]). Degeneration of terminals occurs within the ipsilateral LRt following lesions of the ventrolateral quadrant ([@B19]). These inputs are highly ordered and project to specific regions of the LRt; for example projections from the lumbar cord terminate in the ventral and ventrolateral region of the nucleus whereas those from cervical regions terminate throughout the LRt ([@B25]; [@B7]; [@B34]; see also [@B33]). Although there is general agreement about the spinal organization of SRT cells projecting to the LRt, there is contradictory evidence supporting the existence of SRT neurons that project bilaterally to both nuclei. One study reports that there are almost no bilateral projections ([@B24]) whereas another reports that 7% of SRT cells project to both nuclei ([@B16]). An initial aim of the present study therefore was to re-examine the organization of SRT cells in the lumbar spinal cord following bilateral injections of tracer substances.

Electrical stimulation of the lumbar component of the bVFRT not only evokes strong excitatory responses in LRt neurons but also causes profound inhibition ([@B35], [@B36],[@B37]; [@B12]) and some inhibitory actions are evoked with monosynaptic latencies ([@B13]). There is limited evidence for long ascending inhibitory spinal pathways from the spinal cord to the brain but recently the existence of a long inhibitory pathway to the ventromedial medulla was established by [@B18] in an anatomical study. [@B33], using viral tracing techniques in genetically modified mice reported that lumbar projections to the LRt are almost exclusively excitatory but noted the existence of sparse inhibitory terminals within the most ventromedial region of the LRt. This finding is somewhat at variance with those reported in the electrophysiological study of [@B13] who concluded that excitatory and inhibitory lumbar bVFRT neurones have similar termination areas in the LRt. The principal aim of the present study therefore was to determine if inhibitory and excitatory axon terminals within the LRt arise directly from neurons within the lumbar cord and, if so, to determine if they are segregated anatomically within the LRt. We also wished to determine if inhibitory SRT axons form direct contacts with pre-cerebellar LRt neurons and if excitatory and inhibitory SRT terminations converge on these cells.

MATERIALS AND METHODS {#s1}
=====================

A series of anatomical tract tracing experiments was undertaken on nine adult male Sprague Dawley rats (250--350 gm Harlan, Bicester, UK). These experiments were conducted according to British Home Office legislation and were approved by the University of Glasgow Ethics Committee for Animal Research. In the first series of experiments bilateral injections were made in the left and right LRt of three animals to label SRT cells in the lumbar spinal cord retrogradely. In the second series, the ventral quadrant of the lumbar cord of six rats was injected with the b subunit of CTb and terminals in the LRt were examined for immunoreactivity for VGLUTs (VGLUT1 and VGLUT2) and the VGAT to identify excitatory and inhibitory terminals, respectively. A final series of experiments was performed where we examined the relationships formed by these axons with pre-cerebellar LRt neurons that project to the anterior lobe of the cerebellum where LRt cells with input from the lumbar component of the SRT are known to form terminations ([@B1]).

SURGICAL PROCEDURES
-------------------

Surgery was performed on animals induced and maintained under general anesthesia with 2--4% Isoflurane in oxygen.

In order to label SRT cells, three adult male Sprague Dawley rats were placed in a strereotaxic frame. Two different retrograde tracers were injected into the left and right LRt. On the left side 200 nl of the b subunit of CTb (Sigma--Aldrich, Co., Poole, UK; 1% in sterile distilled water) was pressure injected at inter-aural co-ordinates -4.8 mm (antero-posterior), +1.8 mm (medio-lateral) and at a dorso-ventral coordinate of -0.4 mm ([@B32]). The micropipette was left in place for 5 min to prevent any backflow of the tracer and then emptied by ejecting the remaining CTb on to a cotton bud and cleaned by drawing up sterile distilled water and ejecting it several times. The outer surface of the tip was cleaned with distilled water on a sterile cotton bud. A second burr hole was made on the right side at interaural co-ordinates -4.8 mm (antero-posterior) and -1.8 mm (medio-lateral). The pipette was then filled with 50 nl of 4% Fluorogold (FG) in distilled water (Fluorochrome, LLC, USA) and pressure injected into the right LRt at a dorso-ventral coordinate of -0.4 mm. The pipette was again left in place for 5 min and then removed. The scalp was sutured and animals were allowed to recover.

To label axon terminals projecting to the LRt, six rats were mounted in a spinal frame and the Th13 vertebra was identified by its attachment to the last rib. A small dorsal midline incision extending from Th10 to L3 vertebrae was made. The laminar surface of the second lumbar vertebra was exposed (on the right side of the animal) and a small burr hole was created on the right side adjacent to the midline. A glass micropipette was then inserted to a depth of ∼1.5 mm into the spinal cord at an angle of 15 and 100 nl of CTb was injected by using a Pico--Injector (World Precision Instruments, Sarasota, FL, USA). Following a period of 48 h three of these animals were anesthetized with Isoflurane as described above and placed in a stereotaxic frame. These animals were given stereotaxic injections of FG (50 nl of 4% in sterile distilled water) within the anterior cerebellum via a glass micropipette (inter-aural co-ordinates, dorso--ventral +6 mm, antero--posterior -1.6 mm, and medio-lateral -0.5 mm; [@B32]).

All animals were given subcutaneous injections of Rimadyl 0.1 ml/100 gm (Carprofen 50 mg/ml, Pfizer, Dumfries, UK) and 0.15 ml/100 gm Vetergesic (Buprenorphine 0.3 mg/ml, Reckitt Benckiser Healthcare, Dumfries, UK) postoperatively.

FIXATION
--------

Following a 6 day survival period after the initial surgical procedure, rats were anesthetized with pentobarbitone (1 ml i.p.) and perfused through the left ventricle with mammalian Ringer's solution followed by one liter of a fixative containing 4% formaldehyde in 0.1 M PB (pH 7.4) at room temperature. Brains and spinal cords were removed and placed in the same fixative overnight except that 30% sucrose was added to the fixative for brains to cryoprotect brain tissue to be sectioned on a freezing microtome.

INJECTION SITES
---------------

To examine LRt injection sites, 100 μm coronal sections of the medulla were sectioned with a freezing microtome (Leica, UK). Alternate sections were reacted for CTb. Sections were incubated in goat anti- CTb for 48 h followed by biotinylated anti-goat IgG for 3 h at room temperature prior to incubation in avidin-HRP for 1 h and hydrogen peroxide plus DAB for a period of approximately 15 min. They were then mounted on gelatin-coated slides, dehydrated, cleared, and a coverslip was applied. Adjacent sections were mounted with anti-fade medium (Vectashield, Vector Laboratories, Peterborough, UK) on glass slides.

Spinal cord segments containing injection sites were sectioned (transverse 50 μm sections) with a Vibratome (Oxford instruments, Technical products international Inc. USA) and reacted to reveal CTb as described above for medullary sections. For animals with FG injections in the cerebellum, the cerebellum was detached from the brainstem, sectioned with a freezing microtome (100 μm coronal sections) and mounted with Vectashield on glass slides.

Injection sites containing CTb were viewed with light microscopy, whilst those containing FG were viewed with epifluorescence. Sections were photographed digitally (AxioVision 4.8 software, Zeiss, Germany) and the location of each injection site was determined from captured digital images with reference to the stereotaxic rat brain atlas of [@B32].

IMMUNOREACTIONS
---------------

Immunoreactions were performed on 50 μm coronal Vibratome sections of the spinal cord and medulla according to the details listed in **Table [1](#T1){ref-type="table"}**. All sections were treated with an aqueous solution of 50% ethanol for 30 min to enhance antibody penetration. Briefly, sections were incubated in combinations of primary antibodies (see **Table [1](#T1){ref-type="table"}**) for 48 h. Sections were then washed several times with 0.1 M PBS that contained 0.3 M NaCl (PBS) before transferring them to combinations of secondary antibodies conjugated to fluorophores for 3 h. After a final wash in PBS, sections were mounted with anti-fade medium, Vectashield (Vector Laboratories, Peterborough, UK) on glass slides.

###### 

Antibodies used in the study.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Experiment   Primary antibody combination   Primary antibody concentration   Supplier                               Secondary antibody combination   Secondary antibody concentration   Supplier
  ------------ ------------------------------ -------------------------------- -------------------------------------- -------------------------------- ---------------------------------- ----------------------------------------------
  1            gt CTb\                        1:5000\                          List (Quadratech), Campbell,\          Rh. Red\                         1:100\                             Jackson Immunoresearch, West Grove, PA, USA\
               \                              \                                CA, USA\                               \                                \                                  \
               rbt FG                         1:5000                           Chemicon/Millipore, CA, USA            \                                \                                  Molecular probes, Eugene, OR, USA
                                                                                                                      Alexa 488                        1:500                              

  2A           gt CTb                         1:5000                           List (Quadratech), Campbell, CA, USA   Rh. Red                          1:100                              Jackson Immunoresearch, West Grove, PA, USA

               gp VGLUT1&2                    1:5000                           Chemicon, Harlow, UK                   Alexa 647                        1:500                              Molecular probes, Eugene, OR, USA

               rbt VGAT                       1:5000                           Synaptic systems, Göttingen, Germany   Alexa 488                        1:500                              Molecular probes, Eugene, OR, USA

  2B           gt CTb                         1:5000                           List (Quadratech)                      Rh. Red                          1:100                              Jackson Immunoresearch, West Grove, PA, USA

               gp VGLUT1                      1:5000                           Chemicon, Harlow, UK                   Alexa 647                        1:500                              Molecular probes, Eugene, OR, USA

               rbt VGLUT2                     1:5000                           Chemicon, Harlow, UK                   Alexa 488                        1:500                              Molecular probes, Eugene, OR, USA

  2C           gt CTb                         1:5000                           List (Quadratech)                      Rh. Red                          1:100                              Jackson Immunoresearch, West Grove, PA, USA

               gp GLYT2                       1:10000                          Chemicon, Harlow, UK                   Alexa 488                        1:500                              Molecular probes, Eugene, OR, USA

               rbt GAD 65&67                  1:1000                           Sigma                                  Alexa 647                        1:500                              Molecular probes, Eugene, OR, USA

  3            gt CTb                         1:5000                           List (Quadratech)                      Rh. Red                          1:100                              Jackson Immunoresearch, West Grove, PA, USA

               rbt FG                         1:5000                           Chemicon/Millipore, CA, USA            Alexa 488                        1:500                              Molecular probes, Eugene, OR, USA

               gpig VGLUT2                    1:5000                           Chemicon, Harlow, UK                   Alexa 647                        1:500                              Molecular probes, Eugene, OR, USA

               mo VGAT                        1:1000                           Synaptic systems, Göttingen, Germany   mo Biotin AV-PB                  1:500 1:1000                       Molecular probes, Eugene, OR, USA
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

gt, goat; rbt, rabbit; mo, mouse; gp, guinea pig; FG, Fluorogold; CTb, the b subunit of cholera toxin; VGLUT1, vesicular glutamate transporter 1; VGLUT2, vesicular glutamate transporter 2; VGAT, vesicular GABA transporter; GLYT2, glycine transporter 2; GAD 65+67 = 65 and 67 isoforms of glutamate decarboxylase; Rh. Red, rhodamine red; Mo Biotin AV-PB, mouse biotin, avidin-pacific blue. In Experiment 1A tissue was incubated in a mixture of VGLUT1+2 antibodies.

IMAGING AND DATA ANALYSIS
-------------------------

Sections were analyzed with a confocal microscope (LSM 710, Zeiss, Germany).

To examine retrogradely labeled SRT cells, spinal cord sections (three sections from L3, L4, and L5 for each animal) were tile scanned through their full thickness with the confocal microscope at a magnification of x10 (1.4 zoom at 2 μm steps). CTb, FG, and double-labeled cells were plotted and counted by using Neurolucida for Confocal (MBF Bioscience, Colchester, VT, USA) software. The first and last two optical sections were excluded from the analysis to minimize counting errors. The locations of cells were plotted on to outline diagrams. The proportions of cells of each type (ipsilateral, contralateral, and bilateral) were expressed as a percentage which was averaged for the three animals.

To examine terminals in the LRt, tile scans of 5 × 3 image stacks covering the LRt were taken (magnification 40X lens, zoom factor 1.4, each stack consisting of 20 z-steps at 0.5 μm intervals) were made from two sections (ipsilateral LRt) or two sections (contralateral LRt) per animal taken from interaural coordinates a levels -4.92 and -5.40 mm. Single optical sections from image stacks consisting of 20 optical sections were viewed with Neurolucida for Confocal. Initially sections were viewed in the red channel so that only CTb immunoreactivity was visible. Terminals were defined as axonal swellings that ranged between 0.5 and 3 μm in diameter. A grid consisting of 25 μm × 25 μm squares was superimposed upon the individual sections and for each square, the CTb labeled terminal closest to the bottom left corner was marked with a symbol for analysis. This procedure was repeated until the entire LRt had been sampled within each stack. Annotated terminals were subsequently examined in the blue and green channels in order to assess expression of transmitter-related markers. The percentage of terminals expressing each of the markers was then calculated and averaged for the six animals.

Contacts on pre-cerebellar LRt neurons containing FG made by CTb labeled axon terminals were investigated for the presence of VGLUT2 and VGAT immunoreactivity. In total 33 cells were investigated (11 each from animals 1--3). Pre-cerebellar LRt neurons were reconstructed from confocal images with Neurolucida for Confocal and the location of CTb contacts was plotted onto the reconstructions. A contact was defined as a close apposition between a labeled terminal and a cell where no intervening dark pixels were present. The numbers of contacts containing VGLUT2 or VGAT were counted and the contact density of the two types of terminals in contact with cells was expressed as numbers of contacts per 100 μm^2^ units of the neuronal surface area which was calculated using the Neuroexplorer facility of Neurolucida.

Data are expressed as mean ± SD and multiple comparisons were made using ANOVA with *post hoc* Tukey's correction (*p* \< 0.05).

RESULTS
=======

RETROGRADELY LABELED SRT CELLS
------------------------------

Injection sites for CTb and FG medullary injections were focussed on the LRt but a penumbra of diffuse staining which encroached upon the intermediate and parvicellular reticular nuclei was present in all three animals (**Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}**). Injections of CTb and FG labeled cells on both sides of the gray matter in all three spinal segments were analyzed (**Table [1](#T1){ref-type="table"}**, Experiment 1). The total numbers of SRT cells counted for each animal ranged from 656 to 796 but FG injections produced greater numbers of cells (63% of all cells labeled). The largest numbers of cells were found contralateral to their respective injection sites: 56% (±6.38 SD) of CTb-labeled cells and 61% (±9.9 SD) of FG-labeled cells. However, small numbers of cells on both sides of the gray matter were double-labeled for FG and CTb: 10% (±4.7 SD) and 7% (±2.87 SD) on the right and left sides of sections, respectively (**Figure [3](#F3){ref-type="fig"}**). The majority of cells, both contralateral and ipsilateral to injection sites were located within medial areas of lamina VI and VII and within lamina X. Additional populations were found within the reticulated region of lamina V and small numbers were present in lamina I. In the L5 segment, cells were also present in Lamina VIII (see **Figure [2](#F2){ref-type="fig"}**).

![**Injections sites in the medulla.** **(A)** A CTb injection site **(B)** An adjacent section showing a combined dark-field and epifluorescence image showing Fluorogold (FG) within the LRt and surrounding reticular formation. A schematic version of these injections is shown in **Figure [2A](#F2){ref-type="fig"}**. LRt, lateral reticular nucleus, mlf, medial longitudinal fasciculus, py, pyramid.](fnana-09-00001-g001){#F1}

![**Bilateral medullary injection sites and distribution of spinoreticular tract (SRT) cells in lumbar segments from 3 animals (A--C).** FG injections are shown as yellow and CTb as black. Diffuse spread of tracer is shown as gray. Distribution of cells for three segments (L3--L5) is shown on schematic diagrams of transverse sections. Each diagram represents a composite analysis of 3 μm × 50 μm sections from the three segments. Green stars, FG labeled cells; Red circles, CTb labeled cells; black dots, cells labeled with both tracers.](fnana-09-00001-g002){#F2}

![**Confocal microscope images of spinal cells labeled with FG (green) and CTb (red).** The main plate is a tiled image of an entire L3 transverse section. The areas demarcated by boxes 1 and 2 illustrate examples of double labeled cells within laminae VII and V, respectively, and are shown as single optical sections at higher magnification below (1 and 2). Scale bars: Main plate = 200 μm; 1 and 2 = 20 μm.](fnana-09-00001-g003){#F3}

SPINAL INJECTION SITES AND DISTRIBUTION OF TERMINALS IN THE LRt
---------------------------------------------------------------

For five animals (animals 1 and 3--6), injections of CTb were within the L4 segment but for one animal the injection was located in T11 (animal 2). For animals 1--5, CTb labeling was most intense within the right ventrolateral to ventromedial regions of segments L1--4 but CTb spread throughout the ventral horn and extended into the intermediate gray matter but there was no spread to the left side of the cord (**Figure [4](#F4){ref-type="fig"}**). In one animal (animal 6) the injection was concentrated within the intermediate gray matter (**Figure [4](#F4){ref-type="fig"}**) but there was spread of CTb into the ventral horn and ventral white matter. In all animals, large numbers of anterogradely labeled axons were concentrated in the LRt ipsilateral to the spinal injection and considerably fewer terminals were present in the contralateral side (**Figure [5](#F5){ref-type="fig"}**). The ratio of ipsilateral versus contralateral terminals was 2.6 to 1. In the rat, the LRt extends from interaural co-ordinate -4.32 to -6.00 mm ([@B32]) but the largest regions are found between -4.68 to -5.16 mm and it is in this region that the greatest concentration of labeled terminals was observed. The concentration of terminals progressively declines more rostrally especially in the magnocellular areas. Mediolaterally the distribution follows the various shapes of the LRt but the greatest terminal density is found in the intermedio-medial area. Caudally, terminals were most concentrated in ventral regions of the LRt especially within the parvicellular part of the nucleus.

![**Spinal injection sites.** **(A)** Photomicrograps of the L4 spinal segment showing CTb injection site for animals 4 and 5. The drawings **(B)** show the spread of CTb within the gray and white matter. The dark region represents the core of the injection and the gray region the spread of CTb. Spinal injections are in L4 with the exception of animal 2 which was in T11. Note that the core of most injections is within the ventral quadrant of the cord except for animal 6 where it was in the intermediate gray matter. Animals 1--3 were also used in experiments to label precerebellar cells.](fnana-09-00001-g004){#F4}

![**(A)** A photomicrograph showing a coronal section through the medulla the areas demarcated by boxes on the left and the right are shown at high magnification in **(B)** and **(C),** respectively, which show terminal labeling within the LRt contralateral and ipsilateral to the spinal injection site. Note the particularly large numbers of terminals in the ipsilateral LRt. **(D)** A representation of **A** (based on [@B32]) with terminal locations plotted to show their relationships with medullary structures (right = contralateral to spinal injection; -14.4 relative to Bregma). LRt, lateral reticular nucleus; LRtPC lateral reticular nucleus, parvicellular part; MdV, medullary reticular nucleus; mlf, medial longitudinal fasciculus; py, pyramid. Scale bar for **(B,C)** = 100 μm.](fnana-09-00001-g005){#F5}

IMMUNOCHEMICAL PROPERTIES OF SRT AXON TERMINALS IN THE LRt
----------------------------------------------------------

Confocal microscope images of SRT axon terminals in the ipsilateral and contralateral LRt labeled according to the procedures in **Table [1](#T1){ref-type="table"}[2A--C](#T2){ref-type="table"}** are shown in **Figure [6](#F6){ref-type="fig"}**. Data concerning these experiments are provided in **Table [2](#T2){ref-type="table"}**. To determine the percentages of excitatory and inhibitory SRT terminals in the LRt, sections were reacted to reveal CTb, VGAT and a combination of VGLUT1 and 2 (Experiment 2A, **Table [1](#T1){ref-type="table"}**). In total 4401 CTb terminals were counted in the side ipsilateral to the injection site and although most of the terminals were immunoreactive for VGLUTs (76.9 ± 3.0%: mean ± SD%) a substantial number was reactive for VGAT (20.1 ± 3.1%). In order to clarify what types of VGLUTs are present in CTb-labeled terminals in the LRt, sections were reacted to reveal CTb, VGLUT1 and VGLUT2 (Experiment 2B, **Table [1](#T1){ref-type="table"}**). A total of 2410 terminals was examined through stacks of tile scans of the LRt. Analysis of these scans revealed that 74.9 (±2.8) % of the terminals was immunopositive for VGLUT2 but only a very small percentage (1.8 ± 0.6%) of terminals was immunoreactive for VGLUT1 (**Table [2](#T2){ref-type="table"}**). A total of 2732 CTb-labeled terminals was examined to investigate further the nature of the inhibitory subpopulation (Experiment 2C, **Table [1](#T1){ref-type="table"}**). Analysis of confocal microscope images (**Figures [6D--F](#F6){ref-type="fig"}**) revealed that the percentage of inhibitory terminals labeled by GAD, GLYT2 or with both GAD and GLYT2 was 4.9 ± 0.5, 12.7 ± 2.0% and 4.9 ± 1.0%, respectively, of the total numbers of CTb-labeled terminals). There was no obvious segregation of CTb terminals labeled with VGLUT and VGAT as both types of terminal were present in overlapping areas within the LRt.

###### 

Percentages of immunoreactive terminals in the ipsi- and contralateral lateral reticular nuclei anterogradely labeled from spinal injections of the b subunit of CTb into L3 and 4 segments.

  Ipsilateral   Contralateral                                                                                                                     
  ------------- --------------- ------------ ------------ --------------- ---------- -- --- ----------- ------------ ------------ --------------- ----------
  1             768             77.5         18.4         1.7             2.5           1   189         73.5         22.8         1.1             2.6
  2             801             73.8         23.3         1.1             1.7           2   439         74.5         22.8         0.9             1.8
  3             853             76.1         21.6         0.8             1.5           3   238         76.5         20.2         1.3             2.1
  4             498             79.5         17.9         0.2             2.4           4   147         73.6         21.7         0.8             3.9
  5             755             73.6         23.6         0.7             2.1           5   363         73.2         23.4         0.3             3.1
  6             726             80.9         16.1         1.4             1.7           6   315         81.6         15.9         1.6             1.0
                **Mean%**       **76.9**     **20.1**     **1.0**         **2.0**           **Mean%**   **75.5**     **21.1**     **1.0**         **2.4**
                ±SD             3.0          3.1          0.5             0.4               ±SD         3.2          2.8          0.4             1.0
                                                                                                                                                  
                                **VGLUT1**   **VGLUT2**   **VGLUT1&2**    **CTb**                       **VGLUT1**   **VGLUT2**   **VGLUT1&2**    **CTb**
  1             391             2.0          77.5         0.5             19.9          1   84          1.2          78.6         1.2             19.0
  2             396             1.3          71.5         1.3             26.0          2   215         0.9          77.7         0.9             20.5
  3             389             1.8          73.5         0.3             24.4          3   123         0.8          82.1         0.0             17.1
  4             174             2.9          75.9         2.9             18.4          4   167         1.2          72.5         0.6             25.7
  5             359             1.1          72.7         0.8             25.3          5   194         2.1          74.7         2.1             21.1
  6             701             2.0          78.5         0.6             19.0          6   230         2.6          74.3         3.0             20.0
                **Mean%**       **1.8**      **74.9**     **1.1**         **22.2**          **Mean%**   **1.5**      **76.7**     **1.3**         **20.6**
                ±SD             0.6          2.8          1.0             3.4               ±SD         0.7          3.5          1.1             2.9
                                                                                                                                                  
                                **GAD**      **GLYT2**    **GAD&GLYT2**   **CTb**                       **GAD**      **GLYT2**    **GAD&GLYT2**   **CTb**
  1             490             4.9          14.5         5.9             74.7          1   193         7.3          10.4         6.2             76.2
  2             408             4.7          15.0         4.9             75.5          2   258         6.2          10.9         5.0             77.9
  3             363             4.7          12.5         5.0             77.7          3   89          4.5          13.5         5.6             76.4
  4             403             4.5          12.7         3.0             79.9          4   257         10.1         10.1         2.7             77.0
  5             541             5.9          12.4         5.0             76.7          5   318         7.2          12.9         4.1             75.8
  6             527             4.7          9.3          5.5             80.5          6   309         7.4          10.0         4.9             77.7
                **Mean%**       **4.9**      **12.7**     **4.9**         **77.5**          **Mean%**   **7.1**      **11.3**     **4.8**         **76.8**
                ±SD             0.5          2.0          1.0             2.3               ±SD         1.8          1.5          1.2             0.9

VGLUT1, vesicular glutamate transporter 1; VGLUT2, vesicular glutamate transporter 2; VGAT, vesicular GABA transporter; GLYT2, glycine transporter 2; GAD glutamate decarboxylase. VGLUT1+2, tissue incubated in a mixture of both antibodies, CTb, terminals only immunoreactive for the b subunit of cholera toxin.

![**Single optical sections showing immunochemical properties of axon terminals projecting from the lumbar spinal cord in the lateral reticular nucleus ipsilateral to the spinal injection.** **(A)** An overview of terminals within the LRt labeled for CTb, VGLUT1+2, and VGAT. The area demarcated by the box is shown in series **(B,C)**. **(B)** CTb terminals (red) that are labeled for VGLUT1+2 **(B',B")**. **(C)** CTb terminals that are labeled for VGAT **(C',C")**. A merged image from both series is shown on the right adjacent to **(B")**. **(D)** CTb terminals that are labeled for GlyT2 **(D')** and GAD **(D")**. **(E)** Terminals that are labeled for GlyT2 **(E')** but not GAD **(E")**. **(F)** Terminals that are not labeled for GlyT2 **(F')** but are labeled for GAD **(F")**. Arrows indicate double-labeled structures in each series. VGLUT1+2, vesicular glutamate transporter 1 and vesicular glutamate transporter 2; VGAT, vesicular GABA transporter; GLYT2, glycine transporter 2; GAD glutamate decarboxylase. Scale bars **(A)** = 10 μm, **(B,C)** = 5 μm, **(D--F)** = 5 μm.](fnana-09-00001-g006){#F6}

Although fewer terminals were present within the LRt contralateral to the injection site, the pattern of immunoreactivity was similar to the ipsilateral LRt (**Table [2](#T2){ref-type="table"}**). For combined VGLUT1 and 2 antibodies, 75.5 ± 3.2% of terminals was positively labeled whereas 21.1 ± 2.8% was labeled for VGAT. Similar numbers of contralateral terminals were labeled for VGLUT 2 in Experiment 2A (74.9 versus 76.7%) and for Experiment 2C terminals labeled for GAD, GLYT2, and both markers were present in similar proportions to the ipsilateral side. None of these values were significantly different from the ipsilateral side (ANOVA).

ANALYSIS OF CONTACTS MADE BY SRT AXON TERMINALS AND PRE-CEREBELLAR NEURONS IN THE LRt
-------------------------------------------------------------------------------------

In these experiments we examined contacts from the ipsilateral SRT only. FG injections were made into the anterior lobe of the cerebellum (Focused on lobules III, IV, V) and injections of CTb were made into the right side of lumbar spinal segments (**Figure [7](#F7){ref-type="fig"}**). Injections of FG in the cerebellum resulted in extensive labeling of pre-cerebellar neurons in the medulla which were mainly confined to the LRt and inferior olivary complex (**Figure [8A](#F8){ref-type="fig"}**). Diameters of neurons labeled within the LRt ranged from 18 to 33 μm. Relationships between ipsilateral SRT terminals and pre-cerebellar neurons in the LRt were assessed by using four channel confocal imaging. Sections were processed to reveal CTb, FG, VGLUT2, and VGAT (Experiment 3, **Table [1](#T1){ref-type="table"}**; see **Figures [8B--D](#F8){ref-type="fig"}**). Of all immunoreactive terminals contacting pre-cerebellar neurons, 54% were VGAT immunoreactive whereas 46% contained VGLUT2; however, 29% of all excitatory contacts on LRt cells originate from the lumbar spinal cord but less than 6% of inhibitory terminals are of spinal origin. Seventeen percent of all contacts on LRt cells were made by spinoreticular terminals but most of these CTb-labeled contacts were VGLUT2 positive (80%) whereas a minority were VGAT-immunoreactive (19%). The average number of CTb-VGLUT2 terminals contacting LRt cells was 21.6 (±10.6 SD) and the average number of CTb--VGAT terminals was 5.1 (±1.6 SD). The average contact density for excitatory SRT terminals cells was found to be 0.14 (±0.10 SD) and 0.59 (±0.38 SD) per 100 μm^2^ for somata and dendrites, respectively, whereas the average density for inhibitory terminals was only 0.08 (±0.05) for somata and 0.12 (±0.02 SD) per100 μm^2^ for dendrites. Full details of contact densities on cell bodies and dendrites are given in **Table [3](#T3){ref-type="table"}**. All cells analyzed received contacts from VGLUT2 containing SRT terminals and 87% of them received convergent inputs from both inhibitory and excitatory spinal axons.

![**Cerebellum injection sites.** **(A)** A fluorescence micrograph showing a FG injection site within a coronal section of the anterior cerebellum. **(B--D)** Drawings of the core (black) and spread (gray) of FG within lobules 3, 4, and 5 of animals 1--3, respectively, (based on [@B32]).](fnana-09-00001-g007){#F7}

![**Immunochemical properties of contacts on pre-cerebellar neurons in the LRt.** **(A)** A fluorescent micrograph showing a coronal section through the medulla containing pre-cerebellar neurons labeled with FG from the anterior cerebellum. Note the cells within the LRt and the inferior olivary complex (IO). (Gr, Gracile nucleus; mlf, medial longitudinal fasciculus; py, pyramid; Sp5, spinal trigeminal nucleus). **(B)** A single optical section showing a precerebellar neuron (green) with several CTb (red) contacts on it. The contact shown in the box **(C)** is immunoreactive for VGAT **(C--C")** and the contact shown in box **(D)** is immunoreactive for VGLUT2 **(D--D")**. CTb, b subunit of cholera toxin; FG, Fluorogold; VGLUT2, vesicular glutamate transporter 2; VGAT, vesicular GABA transporter. Scale Bars **(B)** = 10 μm; **(C**,**D)** = 5 μm.](fnana-09-00001-g008){#F8}

###### 

Immunochemical properties of contacts on pre-cerebellar cells within the lateral reticular nucleus.

  Animal         VGLUT2     VGAT       VGLUT2/CTb   VGAT/CTb   CTb
  -------------- ---------- ---------- ------------ ---------- ----------
  **SOMA**                                                     
  1              0.40       0.99       0.09         0.08       0.02
  2              0.59       1.01       0.09         0.03       0.00
  3              0.84       1.04       0.26         0.13       0.01
  **Mean**       **0.61**   **1.01**   **0.14**     **0.08**   **0.01**
  SD             0.22       0.03       0.10         0.05       0.01
  **DENDRITE**                                                 
  1              1.02       1.40       0.54         0.13       0.05
  2              1.83       3.71       0.99         0.13       0.04
  3              1.39       1.38       0.23         0.10       0.00
  **Mean**       **1.35**   **2.05**   **0.59**     **0.12**   **0.04**
  SD             0.41       1.34       0.38         0.02       0.03

The table shows average contact packing densities per 100 μm
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for contacts on somata and dendrites for three animals. Eleven cells were examined from each animal. VGLUT2, terminals immunoreactive vesicular glutamate transporter 2 alone; VGAT, terminals immunoreactive vesicular GABA transporter alone; VGLUT2/CTb, VGLUT2 terminals immunoreactive for both CTb and VGLUT 2; VGAT/CTb, terminals immunoreactive for both CTb and VGAT; CTb, terminals only immunoreactive for the b subunit of cholera toxin.

DISCUSSION
==========

In the present study it was found that projections from the lumbar spinal cord terminate mostly within the ipsilateral LRt with fewer projections terminating within the contralateral LRt. This observation seems paradoxical as findings from the present and previous studies indicate that the majorly of SRT cells in the lumbar cord project to the contralateral LRt. A probable explanation for this finding is discussed below. In addition, bilaterally projecting SRT cells were also observed which were present principally within the intermediate gray matter. Our findings were similar to those of [@B16] who reported that roughly 7% of SRT cells with bilateral projections were located mainly in laminae III, IV, VII, and VIII. This is in contrast to the findings of [@B24] who reported that very small numbers (2%) of cells with bilateral projections were present only within the dorsal horn. Lumbar spinal projections to the LRt are predominantly excitatory but there is a significant inhibitory component that consists of three subtypes of axon containing GABA, glycine, or a mixture of GABA and glycine. Similar proportions of excitatory and inhibitory terminals were found in ipsilateral and contralateral projections. The overwhelming majority of ipsilateral SRT terminals (80%) form excitatory contacts with LRt pre-cerebellar neurons and smaller numbers of inhibitory contacts were also formed (∼19%). Many cells received convergent connections from excitatory and inhibitory axons.

TECHNICAL CONSIDERATIONS
------------------------

In this study CTb was used as an anterograde tracer (see [@B14]) to label spinal axons that project to the LRt. CTb is not only taken up by neuronal cell bodies but it is also taken up by axons of passage ([@B5]). Most of our spinal injection sites were focussed upon the ventrolateral/ventromedial region of the cord but there was spread also into the intermediate gray matter. The present and previous studies of retrogradely labeled spinal cells following injections of tracer substances into the LRt ([@B9]; [@B19]; [@B30]; [@B42]; [@B24]; [@B27]) reveal that neurons in laminae VII, VIII, and X project predominantly to the contralateral LRt ([@B30]; [@B42]). The axons of bVFRT neurons ascend in the ventral part of the lateral funiculus ([@B13]) and project contralaterally at the segmental level ([@B17]; [@B28]; [@B36]; [@B13]). Thus a possible explanation of why spinal-LRt projections were found to be mainly to the ipsilateral LRt in our study is that CTb was principally taken up and transported by axons of passage within the gray and white matter. This conclusion is also supported by the classical observations of [@B4] in the cat who used the Marchi method in combination with spinal lesions and more recent observations of [@B34] who found predominant ipsilateral projections to the LRt following unilateral injections of HRP-wheatgerm agglutinin within rat cervical segments. Although many of the labeled axon terminals could belong to the bVFRT, it is not possible to conclude that they originate exclusively from this tract as some injections encompassed more medial regions of the ventral gray and white matter and yet significant projections to the LRt with similar neurochemical profiles were observed.

An additional limitation of the study is that the FG tracing method used to label pre-cerebellar LRt cells does not label entire dendritic trees of neurons and therefore the numbers of excitatory and inhibitory contacts on these cells is likely to have been underestimated as we were only able to produce data regarding contact packing densities associated with somata and first and second order dendrites. Although we cannot be certain that SRT terminals contacting LRt cells form synapses, the presence of vesicular transporters within them confirms that they contain synaptic vesicles; therefore it is likely that many of the contacts observed do represent synaptic associations. Furthermore, studies using combined confocal and electron microscopy (e.g., [@B43]; [@B31]) along with confocal microscopic studies using markers to label postsynaptic densities (e.g., [@B41]) confirm that the vast majority of contacts observed with confocal microscopy between axonal swellings and cells are indeed synaptic. Finally even though our sample of cells was small (33 in total) we were able to detect consistent contact patterns in cells from all three animals; for example almost all cells in the sample had convergent contacts from excitatory and inhibitory SRT axons but in most cases excitatory contacts greatly outnumbered inhibitory ones.

SRT PROJECTIONS TO THE LRt
--------------------------

Previous observations on the rat and cat fit well with our findings showing that lumbar projections were located in ventral and lateral regions of the nucleus ([@B4]; [@B34]). The first studies of spinal projections to the LRt were made by [@B4] using Glees' silver method in adult cats that had received lesions of the cervical and lumbar white matter. This study showed that the principal spinal projections to the LRt travel in the lateral funiculus and revealed that terminations were organized somatotopically within the nucleus. Many spinal projections to the LRt terminate in the parvicellular region and projections from lumbar regions were found predominantly within ventrolateral regions whereas cervical projections were most abundant within dorsomedial regions. [@B34] used wheatgerm agglutinin conjugated to HRP in a study of afferent projections to the LRt in rats. Lumbar injections resulted in terminal labeling in medial and ventrolateral regions of the LRt and encompassed both magnocellular and parvicellular components of the nucleus. A somatotopic arrangement of afferent input to the LRt is consistent with the electrophysiological observations of [@B13] who noted that LRt cells activated by the bVFRT were located in ventrolateral regions of the nucleus. Further evidence for a somatotopic arrangement within the nucleus in the mouse was provided in a recent report using viral tracing methods ([@B33]).

INHIBITORY AND EXCITATORY TERMINALS IN THE LRt
----------------------------------------------

[@B13] provided evidence that electrical stimulation of the ventrolateral quadrant could evoke monosynaptic EPSPs and IPSPs in LRt cells and responses indicated that excitatory and inhibitory SRT neurones terminated in overlapping areas. In this study we have shown that spinal axons within the LRt contain markers for inhibitory and excitatory neurotransmitters and that there is no obvious segregation of excitatory and inhibitory termination sites of axons originating from the lumbar cord (cf. [@B33]). Also inhibitory and excitatory SRT axons form contacts with pre-cerebellar LRt neurons projecting to the anterior lobe of the cerebellum and some cells had convergent contacts form both types of axon. However, [@B13] on the basis of electrophysiological evidence concluded that the bVFRT consisted of roughly equal groups of excitatory and inhibitory neurons whereas we found that excitatory contacts form a significant proportion (29%) of excitatory inputs to these cells whereas inhibitory SRT axons constitute only 6% of inhibitory contacts. The reasons for this apparent discrepancy are unclear, they could be a consequence of the different methodological approaches used (see technical issues above) or may represent a species difference between cats and rats.

Our study indicates that there may be three distinct groups of inhibitory systems projecting to the LRt from the spinal cord; one that is exclusively glycinergic, one that is exclusively GABAergic and one that contains a mixture of both transmitters. Pharmacological information on the LRt is apparently very limited but ligand binding, *in situ* hybridization and immunocytochemical studies show that cells of the LRt express GABA and glycine receptors ([@B15]; [@B2]; [@B40]). However, it is not known how these receptors are organized and whether they are expressed by all LRt neurons or only a subpopulation of cells. Nevertheless it is probable that these subgroups of inhibitory cells exert subtly different effects on their LRt target neurons. In addition to terminals originating from the lumbar spinal cord, pre-cerebellar neurons in the ventral and lateral regions of the LRt have an abundance of excitatory and inhibitory contacts on them. All of these terminals originate from sources within the spinal cord and brain as the LRt contains no interneurons ([@B21],[@B22]).

FUNCTIONAL IMPLICATIONS
-----------------------

The LRt is a complex structure which receives multiple inputs from different lumbar and cervical spinal systems and various brain structures such as the primary motor cortex, red nucleus, and superior colliculus. Cells of the LRt project widely to different regions of the cerebellum and deep cerebellar nuclei. Some of these input/output systems appear to be segregated. As discussed above, spinal terminations within the LRt are arranged somatotopically and this somatotopic organization is conserved by LRt projections to the cerebellum (e.g., see [@B1]). Most LRt cells receive convergent inputs from different spinal and brain systems (e.g., see [@B23]) and therefore the LRt has an integrative function. The cells forming SRT projections to the LRt are located principally in laminae VI, VII, and X where many last order premotor interneurons are located ([@B44]) and therefore one of the functions of this pathway may be to monitor activity of such interneurons. In addition, some individual SRT cells have the capacity to directly influence activity of cells within both the left and right LRt. Thus the spino-bulbar-reticular pathway appears to provide the cerebellum with information that is different and distinct from classical spinocerebellar pathways. The cells of origin of the pathway are located more ventrally to those of the dorsal spinocerebellar pathway and more medially to the cells of the ventral spinocerebellar pathway. Information from the lumbar spinal cord is integrated with vestibular input at the spinal level and with input from a variety of supraspinal sources within the LRt itself. Thus the cerebellum appears to use information provided by the classical 'pure lines' from the spinal cord and compare it with information provided via the indirect pathway in order to make motor adjustments to maintain normal posture during locomotor and other motor behaviors (e.g., see [@B1]).
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bVFRT

:   bilateral ventral flexor reflex tract

CTb

:   cholera toxin B subunit

DAB

:   3,3′-diaminobenzidine

GAD

:   glutamic acid decarboxylase

GLY T2

:   glycine transporter 2

HRP

:   horseradish peroxidise

iFT

:   ipsilateral forelimb tract

IgG

:   immunoglobulin gamma

LRt

:   Lateral reticular nucleus

PB

:   Phosphate buffer

PBS

:   Phosphate buffer saline

PBST

:   phosphate buffer saline containing 0.3% Triton X-100

SD

:   standard deviation

SRT

:   Spinoreticular tract

VGAT

:   vesicular GABA transporter

VGLUT

:   vesicular glutamate transporter
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